Harrow Health Inc. (HROW)
Harrow Health Statistics
Share Statistics
Harrow Health has 35.65M shares outstanding. The number of shares has increased by 0.66% in one year.
| Shares Outstanding | 35.65M |
| Shares Change (YoY) | 0.66% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 58.34% |
| Shares Floating | 29.96M |
| Failed to Deliver (FTD) Shares | 82 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 3.79M, so 10.62% of the outstanding shares have been sold short.
| Short Interest | 3.79M |
| Short % of Shares Out | 10.62% |
| Short % of Float | 15.01% |
| Short Ratio (days to cover) | 6.54 |
Valuation Ratios
The PE ratio is -68.42 and the forward PE ratio is 16.23. Harrow Health's PEG ratio is 1.97.
| PE Ratio | -68.42 |
| Forward PE | 16.23 |
| PS Ratio | 0 |
| Forward PS | 1.3 |
| PB Ratio | 0 |
| P/FCF Ratio | -19.65 |
| PEG Ratio | 1.97 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Harrow Health.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.08, with a Debt / Equity ratio of 0.
| Current Ratio | 2.08 |
| Quick Ratio | 1.96 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | -3.76 |
| Interest Coverage | 387167.56 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $522.55B |
| Profits Per Employee | $-45.76K |
| Employee Count | 382 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 4.6 |
Taxes
| Income Tax | -161B |
| Effective Tax Rate | 0.93% |
Stock Price Statistics
The stock price has increased by 138.06% in the last 52 weeks. The beta is 0.45, so Harrow Health's price volatility has been higher than the market average.
| Beta | 0.45 |
| 52-Week Price Change | 138.06% |
| 50-Day Moving Average | 25.53 |
| 200-Day Moving Average | 35.49 |
| Relative Strength Index (RSI) | 49.55 |
| Average Volume (20 Days) | 510.03K |
Income Statement
In the last 12 months, Harrow Health had revenue of 199,614B and earned -17.48M in profits. Earnings per share was -0.49.
| Revenue | 199,614B |
| Gross Profit | 150,369B |
| Operating Income | 8,822B |
| Net Income | -17.48M |
| EBITDA | 8,822B |
| EBIT | 5.47M |
| Earnings Per Share (EPS) | -0.49 |
Balance Sheet
The company has 47.25M in cash and 228.83M in debt, giving a net cash position of -181.58M.
| Cash & Cash Equivalents | 47.25M |
| Total Debt | 228.83M |
| Net Cash | -181.58M |
| Retained Earnings | -151,385B |
| Total Assets | 388.97M |
| Working Capital | 98.31M |
Cash Flow
In the last 12 months, operating cash flow was -22.2M and capital expenditures -38.67M, giving a free cash flow of -60.88M.
| Operating Cash Flow | -22.2M |
| Capital Expenditures | -38.67M |
| Free Cash Flow | -60.88M |
| FCF Per Share | -1.71 |
Margins
Gross margin is 75.33%, with operating and profit margins of 4.42% and 0%.
| Gross Margin | 75.33% |
| Operating Margin | 4.42% |
| Pretax Margin | -8.68% |
| Profit Margin | n/a |
| EBITDA Margin | 4.42% |
| EBIT Margin | 4.42% |
| FCF Margin | n/a |
Dividends & Yields
HROW does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for HROW is $61, which is 145.7% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $61 |
| Price Target Difference | 145.7% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Feb 8, 2013. It was a backward split with a ratio of 1:5.
| Last Split Date | Feb 8, 2013 |
| Split Type | backward |
| Split Ratio | 1:5 |
Scores
| Altman Z-Score | 2.5 |
| Piotroski F-Score | 2 |